about
Malaria-related anaemia: a Latin American perspectiveMalaria vaccine clinical trials: what's on the horizonGenetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidateQuantifying the removal of red blood cells in Macaca mulatta during a Plasmodium coatneyi infectionImaging effector functions of human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein.From genome-scale data to models of infectious disease: A Bayesian network-based strategy to drive model development.Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia.Plasmodium cynomolgi infections in rhesus macaques display clinical and parasitological features pertinent to modelling vivax malaria pathology and relapse infectionsPromiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon.Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area.Comparative transcriptomics and metabolomics in a rhesus macaque drug administration study.Malaria-related anemia in patients from unstable transmission areas in Colombia.Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individualsA tree-like Bayesian structure learning algorithm for small-sample datasets from complex biological model systemsIn silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant ChimeraInduction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques.Polymeric linear Peptide chimeric vaccine-induced antimalaria immunity is associated with enhanced in vitro antigen loadingA chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119.Case Report: Severe and Complicated Cynomolgi Malaria in a Rhesus Macaque Resulted in Similar Histopathological Changes as Those Seen in Human Malaria.Sequence and diversity of T-cell receptor alpha V, J, and C genes of the owl monkey Aotus nancymaae.A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens.A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice.Sequence and diversity of MHC DQA and DQB genes of the owl monkey Aotus nancymaae.Leishmania: fine mapping of the Leishmanolysin molecule's conserved core domains involved in binding and internalization.In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines.Identification of a differentially expressed mRNA in axenic Leishmania panamensis amastigotes.Immunoglobulin kappa light-chain V, J, and C gene sequences of the owl monkey Aotus nancymaae.Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial.CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein.Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli.A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria.Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.Capsid-incorporation strategy to display antigens for an alternative adenoviral vector vaccine approach
P50
Q26997119-5B9258E8-0ECA-412A-9517-108415D20D33Q28083110-893510C7-6598-439E-975A-43C18C5EBD4DQ28748331-AB0A0906-EDC9-47B6-AACA-00B91A5CBAA4Q28830439-77C8C18B-7E5B-4DE9-966E-430BB1928983Q30497914-1CCAA7B4-2FB9-4204-B814-4DA5BFCFBB38Q30975494-0A712EAB-79DA-4003-8A36-E80B04751C6FQ33422134-8473CC8E-C151-4DC9-B214-1842A8220195Q33435123-E123A454-7437-4AB5-8DB4-C67D49826194Q33817378-33C772B0-9DDD-4436-B13D-349AB98F73D6Q34078790-3B8F8BFB-03AB-4A86-9191-D99A63FBB574Q34125960-9E3A63F8-EE45-445E-864F-C6E289353C66Q34287358-48F9E011-AE1A-4A13-8218-BCE27B0C36DEQ34521873-B625D856-FCF3-43B7-9553-06C77D6BC513Q35140416-EDA55498-F10A-4C84-A6BD-DDF5A76EFB9EQ35606249-8C1E73A7-FC30-47A7-BDCF-A4D83D3DF9EEQ35756595-16703674-20B3-4051-8926-F1DF3F5F057EQ35898819-55B7EAC4-D2BF-4786-9DB6-1C3161BF313AQ35947469-5ABF2322-4F74-4912-ACD4-680CC846A7CDQ36285998-8A15995E-2654-4996-A9A0-98BDEEED22E9Q36867704-1FA6E4A4-A617-4757-A6F8-8CDE5592B769Q37191389-1AFE6C6C-B7D2-440C-BDAA-96BFB9F34624Q37314756-22F823C8-223E-4574-9565-6A8EABFB18E7Q38614220-F71BA3AD-FBBA-4550-BDE7-593AD894D177Q39000881-074C47A6-00B1-4C0E-97C5-938669CCBEEDQ39441716-C2F3314F-92EC-45C0-9FEE-431C1460D1DCQ40210139-0C40CA56-44D0-407B-9D11-815EFD676E67Q40755540-161B5CFA-00BF-4308-93E6-E0A8981D8D3CQ40932991-17E2AEC8-6654-485F-9881-D40BDE8C4FEBQ41430947-B625AFC5-853A-4490-80B7-2340A9E48407Q42659896-1A1BD0CF-97C2-4CA4-AC86-82CC13B24E45Q43565173-CDCD0F5C-6DEA-4BC2-B9ED-82497F978262Q43573317-54E30AC6-CF73-4674-85FD-90ACB81B8ADDQ46255231-C7FFE158-25EC-4392-A42A-C138A8D75862Q47664368-4871A0A0-06FF-44D4-9FB9-C18031BF2834Q47887725-A5333C9A-774B-482F-982C-1D9EA7B6EF92Q47904576-AAECF629-669E-407F-BC33-E9085090EF84Q48013929-78E4618C-6E93-4710-AEA4-E0972ED6828EQ48018193-B8C9BF3F-8FCE-4EE8-AA60-EDD860EF6AB0Q52719272-322EDFE7-769C-42EA-9C10-AD712FF180DEQ57788235-B3B1EAB4-81AE-43C6-9299-AF7D9592AD51
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
A Moreno
@ast
A Moreno
@en
A Moreno
@es
A Moreno
@nl
type
label
A Moreno
@ast
A Moreno
@en
A Moreno
@es
A Moreno
@nl
prefLabel
A Moreno
@ast
A Moreno
@en
A Moreno
@es
A Moreno
@nl
P108
P31
P496
0000-0002-3031-7194